- Home
- GWRE vs RDY Comparison
GWRE vs RDY Comparison
Compare GWRE & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRE
- RDY
- Stock Information
- Founded
- GWRE 2001
- RDY 1984
- Country
- GWRE United States
- RDY India
- Employees
- GWRE N/A
- RDY N/A
- Industry
- GWRE Computer Software: Prepackaged Software
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- GWRE Technology
- RDY Health Care
- Exchange
- GWRE Nasdaq
- RDY Nasdaq
- Market Cap
- GWRE 11.5B
- RDY 13.1B
- IPO Year
- GWRE 2012
- RDY N/A
- Fundamental
- Price
- GWRE $192.22
- RDY $14.17
- Analyst Decision
- GWRE Buy
- RDY Buy
- Analyst Count
- GWRE 15
- RDY 1
- Target Price
- GWRE $175.00
- RDY $17.00
- AVG Volume (30 Days)
- GWRE 694.0K
- RDY 697.0K
- Earning Date
- GWRE 12-05-2024
- RDY 11-05-2024
- Dividend Yield
- GWRE N/A
- RDY 6.76%
- EPS Growth
- GWRE N/A
- RDY 4.63
- EPS
- GWRE N/A
- RDY 0.76
- Revenue
- GWRE $980,497,000.00
- RDY $3,579,112,656.00
- Revenue This Year
- GWRE $18.61
- RDY $13.39
- Revenue Next Year
- GWRE $14.62
- RDY $8.35
- P/E Ratio
- GWRE N/A
- RDY $19.00
- Revenue Growth
- GWRE 8.30
- RDY 12.37
- 52 Week Low
- GWRE $95.02
- RDY $12.90
- 52 Week High
- GWRE $199.33
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- GWRE 59.43
- RDY 30.39
- Support Level
- GWRE $194.31
- RDY $14.99
- Resistance Level
- GWRE $199.33
- RDY $15.19
- Average True Range (ATR)
- GWRE 2.76
- RDY 0.28
- MACD
- GWRE -0.12
- RDY -0.07
- Stochastic Oscillator
- GWRE 51.89
- RDY 11.43
About GWRE Guidewire Software Inc.
Guidewire Software provides software solutions for property and casualty insurers. Flagship product InsuranceSuite is an on-premises system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a cloud-based offering, as well as a variety of other add-on applications.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.